Sho Joseph Ozaki Tan is the founder of the Public Longevity Group and a biomedical researcher focused on the intersection of science, culture, and systems change. Trained at Imperial College London, he led ageing research on Alzheimer’s and reproductive longevity at the Buck Institute and the Max Planck Institute for Biology of Ageing. He held additional research roles at Stanford and Kyoto University.
Sho brings cross-sector experience in biotech strategy, health tech consulting, and narrative intelligence. He previously worked at Inflection Point Biomedical Advisors health tech consulting in Japan and contributed to the early development of the cultured meat startup Multus. A TIME Fellow, Norn Fellow, and Longevity Biotech Fellow, he now leads the Public Longevity Group at the Lifespan Research Institute to build the cultural infrastructure the longevity enterprise needs to earn public trust.
